Trade BBNX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Beta Bionics, Inc. (BBNX) is trading at US$19.42, down 2.51% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$857.05M. Over the past 52 weeks, BBNX has traded between US$8.80 and US$32.71. On Syfe you can trade BBNX with $0 commission and add it to your watchlist.
| Previous close | US$19.92 |
|---|---|
| Market cap | US$857.05M |
| 52-week range | US$8.80 – US$32.71 |
| Volume | 1.41M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Beta Bionics, Inc.
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
Year: 2025
UBS Adjusts Price Target on Beta Bionics to $22 From $24, Maintains Buy Rating
Jul 28, 2:22 PM · MT Newswires
Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating
Jul 13, 11:15 AM · MT Newswires
Beta Bionics Expects Commercialization of Mint Insulin Patch Pump in 2027
May 21, 8:40 PM · MT Newswires
Beta Bionics, Inc. (BBNX) stock is trading at US$19.42, -2.51% from the previous close of US$19.92.
The market cap for Beta Bionics, Inc. (BBNX) stock is approximately US$857.05M.
The 52-week high for Beta Bionics, Inc. (BBNX) stock is US$32.71.
The 52-week low for Beta Bionics, Inc. (BBNX) stock is US$8.80.
Beta Bionics, Inc. (BBNX) does not currently pay a dividend.
Stay on top of BBNX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
